摘要 |
The present invention provides compounds of Formula (I): Formula (I) or a stereoisomer, tautomer, pharmaceutically acceptable salt or solvate form thereof, wherein the variables A, L<SUB>1</SUB>, M and R<SUP>11</SUP> are as defined herein. The compounds of Formula (I) are selective inhibitors of serine protease enzymes of the coagulation cascade and/or contact activation system; for example thrombin, factor Xa, factor XIa, factor IXa, factor VIIa and/or plasma kallikrein. In particular, it relates to compounds that are selective factor XIa inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same.
|
申请人 |
BRISTOL-MYERS SQUIBB COMPANY;PINTO, DONALD, J.P.;SMALLHEER, JOANNE, M.;CORTE, JAMES R.;HU, ZILUN;CAVALLARO, CULLEN L.;GILLIGAN, PAUL, J.;QUAN, MIMI L. |
发明人 |
PINTO, DONALD, J.P.;SMALLHEER, JOANNE, M.;CORTE, JAMES R.;HU, ZILUN;CAVALLARO, CULLEN L.;GILLIGAN, PAUL, J.;QUAN, MIMI L. |